Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Paul Clayton, Silma Subah, Ruchitha Venkatesh, Mariko Hill & Nathasha Bogoda. (2023) Palmitoylethanolamide: A Potential Alternative to Cannabidiol. Journal of Dietary Supplements 20:3, pages 505-530.
Read now
Read now
Uma Anand, Ben Jones, Yuri Korchev, Stephen R Bloom, Barbara Pacchetti, Praveen Anand & Mikael Hans Sodergren. (2020) CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons. Journal of Pain Research 13, pages 2269-2278.
Read now
Read now
Constantin Itin, Abraham J Domb & Amnon Hoffman. (2019) A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states. Expert Opinion on Drug Delivery 16:10, pages 1031-1035.
Read now
Read now
Amit K. Goyal, Ranjit Singh, Gaurav Chauhan & Goutam Rath. (2018) Non-invasive systemic drug delivery through mucosal routes. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 539-551.
Read now
Read now
Irene Moreno Torres, Antonio J Sanchez & Antonio Garcia-Merino. (2014) Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis. Expert Review of Neurotherapeutics 14:11, pages 1243-1250.
Read now
Read now
Radu Tanasescu, David Rog & Cris S Constantinescu. (2011) A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’. Expert Opinion on Drug Discovery 6:4, pages 437-452.
Read now
Read now
Matthias Karst & Sonja Wippermann. (2009) Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective. Expert Opinion on Investigational Drugs 18:2, pages 125-133.
Read now
Read now
Articles from other publishers (41)
Md Moniruzzaman, Taskeen Iqbal Janjua, Jennifer H. Martin, Jakob Begun & Amirali Popat. (2024) Cannabidiol - Help and hype in targeting mucosal diseases. Journal of Controlled Release 365, pages 530-543.
Crossref
Crossref
Ehsan Moazen-Zadeh, Alexandra ChisholmKeren BachiYasmin L. Hurd. (2023) Pharmacokinetics of Cannabidiol: A Systematic Review and Meta-Regression Analysis. Cannabis and Cannabinoid Research.
Crossref
Crossref
Heather Barkholtz & Maia Bates. (2023) Measuring the diversity gap of cannabis clinical trial participants compared to people who report using cannabis. Scientific Reports 13:1.
Crossref
Crossref
Yitong Liu & Robert L. Sprando. (2022) Physiologically based pharmacokinetic modeling and simulation of cannabinoids in human plasma and tissues. Journal of Applied Toxicology 43:4, pages 589-598.
Crossref
Crossref
Mahesh Pattabhiramaiah & Shanthala Mallikarjunaiah. 2023. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases
103
118
.
Gisela Skopp, Matthias Graw & Frank Musshoff. (2022) Cannabidiol – berauschend unberauschend?Cannabidiol—Intoxicatingly nonintoxicating?. Rechtsmedizin 32:6, pages 501-512.
Crossref
Crossref
Gleice Kelli Silva-Cardoso & Christie Ramos Andrade Leite-Panissi. (2022) Chronic Pain and Cannabidiol in Animal Models: Behavioral Pharmacology and Future Perspectives. Cannabis and Cannabinoid Research.
Crossref
Crossref
Markus Dieterle, Laura Zurbriggen, Eckhard Mauermann, Katja Mercer-Chalmers-Bender, Priska Frei, Wilhelm Ruppen & Tobias Schneider. (2022) Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II). Pain 163:10, pages 1919-1928.
Crossref
Crossref
Lucia Grifoni, Giulia Vanti, Rosa Donato, Cristiana Sacco & Anna Rita Bilia. (2022) Promising Nanocarriers to Enhance Solubility and Bioavailability of Cannabidiol for a Plethora of Therapeutic Opportunities. Molecules 27:18, pages 6070.
Crossref
Crossref
C. Austin Zamarripa, Ryan Vandrey & Tory R. Spindle. (2022) Factors that Impact the Pharmacokinetic and Pharmacodynamic Effects of Cannabis: a Review of Human Laboratory Studies. Current Addiction Reports 9:4, pages 608-621.
Crossref
Crossref
Hayley B. Schultz, Adele HosseiniAndrew J. McLachlanStephanie E. Reuter. (2022) Population Pharmacokinetics of Oral-Based Administration of Cannabidiol in Healthy Adults: Implications for Drug Development. Cannabis and Cannabinoid Research.
Crossref
Crossref
Sultan Mayar, Mina Memarpoor-Yazdi, Ahmad Makky, Romina Eslami Sarokhalil & Nazzareno D'Avanzo. (2022) Direct Regulation of Hyperpolarization-Activated Cyclic-Nucleotide Gated (HCN1) Channels by Cannabinoids. Frontiers in Molecular Neuroscience 15.
Crossref
Crossref
Yvonne Bonomo, Amanda Norman, Lisa Collins, Helen O’Neill, Peter Galettis, Jane Trinca, Nigel Strauss, Jennifer Martin & David Castle. (2021) Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study. Pain and Therapy 11:1, pages 171-189.
Crossref
Crossref
Elisa Pabon, Frederica Rockwood, Greg J. Norman & Harriet de Wit. (2021) Acute effects of oral delta‐9‐tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects. Psychophysiology 59:2.
Crossref
Crossref
Deepika E. Slawek, Susanna A. Curtis, Julia H. Arnsten & Chinazo O. Cunningham. (2022) Clinical Approaches to Cannabis. Medical Clinics of North America 106:1, pages 131-152.
Crossref
Crossref
Declan Ryan, Dan S. McKemie, Philip H. Kass, Birgit Puschner & Heather K. Knych. (2021) Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses. Drug Testing and Analysis 13:7, pages 1305-1317.
Crossref
Crossref
John Zewen Chan & Robin Elaine Duncan. (2021) Regulatory Effects of Cannabidiol on Mitochondrial Functions: A Review. Cells 10:5, pages 1251.
Crossref
Crossref
Lucy H. Silmore, Andrew R. Willmer, Edmund V. Capparelli & Gus R. Rosania. (2021) Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41:4, pages 405-420.
Crossref
Crossref
Daryl Efron, Jeremy L. Freeman, Noel Cranswick, Jonathan M. Payne, Melissa Mulraney, Chidambaram Prakash, Katherine J. Lee, Kaitlyn Taylor & Katrina Williams. (2020) A pilot randomised placebo‐controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability. British Journal of Clinical Pharmacology 87:2, pages 436-446.
Crossref
Crossref
Natasha N. Bondareva Williams, Taylor Russell Ewell, Kieran Shay Struebin Abbotts, Kole Jerel Harms, Keith A. Woelfel, Gregory P. Dooley, Tiffany L. Weir & Christopher Bell. (2021) Comparison of Five Oral Cannabidiol Preparations in Adult Humans: Pharmacokinetics, Body Composition, and Heart Rate Variability. Pharmaceuticals 14:1, pages 35.
Crossref
Crossref
María S. García-Gutiérrez, Francisco Navarrete, Ani Gasparyan, Amaya Austrich-Olivares, Francisco Sala & Jorge Manzanares. (2020) Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders. Biomolecules 10:11, pages 1575.
Crossref
Crossref
Sophie Anne Millar, Ryan Francis Maguire, Andrew Stephen Yates & Saoirse Elizabeth O’Sullivan. (2020) Towards Better Delivery of Cannabidiol (CBD). Pharmaceuticals 13:9, pages 219.
Crossref
Crossref
Lourdes Poyatos, Ana Pilar Pérez-Acevedo, Esther Papaseit, Clara Pérez-Mañá, Soraya Martin, Olga Hladun, Adrià Siles, Marta Torrens, Francesco Paolo Busardo & Magí Farré. (2020) Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review. Medicina 56:6, pages 309.
Crossref
Crossref
John-Mark Fitzpatrick, Eleanor Minogue, Lucy Curham, Harry Tyrrell, Philip Gavigan, William Hind & Eric J. Downer. (2020) MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ9-tetrahydrocannabinol and cannabidiol in human macrophages. Journal of Neuroimmunology 343, pages 577217.
Crossref
Crossref
Sin Yin Lim, Satish Sharan & Sukyung Woo. (2020) Model‐Based Analysis of Cannabidiol Dose‐Exposure Relationship and Bioavailability. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:4, pages 291-300.
Crossref
Crossref
Daryl Efron, Kaitlyn Taylor, Jonathan M Payne, Jeremy L Freeman, Noel Cranswick, Melissa Mulraney, Chidambaram Prakash, Katherine J Lee & Katrina Williams. (2020) Does cannabidiol reduce severe behavioural problems in children with intellectual disability? Study protocol for a pilot single-site phase I/II randomised placebo controlled trial. BMJ Open 10:3, pages e034362.
Crossref
Crossref
Marilyn A. Huestis. 2020. Principles of Forensic Toxicology. Principles of Forensic Toxicology
389
448
.
Abigail M. Freeman, Katherine Petrilli, Rachel Lees, Chandni Hindocha, Claire Mokrysz, H. Valerie Curran, Rob Saunders & Tom P. Freeman. (2019) How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review. Neuroscience & Biobehavioral Reviews 107, pages 696-712.
Crossref
Crossref
Benjamin J Whalley, Hong Lin, Lynne Bell, Thomas Hill, Amesha Patel, Roy A Gray, C Elizabeth Roberts, Orrin Devinsky, Michael Bazelot, Claire M Williams & Gary J Stephens. (2018) Species‐specific susceptibility to cannabis‐induced convulsions. British Journal of Pharmacology 176:10, pages 1506-1523.
Crossref
Crossref
Sonja Elsaid, Stefan Kloiber & Bernard Le Foll. 2019. Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside. Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside
25
75
.
Sophie A. Millar, Nicole L. Stone, Andrew S. Yates & Saoirse E. O'Sullivan. (2018) A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. Frontiers in Pharmacology 9.
Crossref
Crossref
Tomáš Hložek, Libor Uttl, Lukáš Kadeřábek, Marie Balíková, Eva Lhotková, Rachel R. Horsley, Pavlína Nováková, Klára Šíchová, Kristýna Štefková, Filip Tylš, Martin Kuchař & Tomáš Páleníček. (2017) Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC. European Neuropsychopharmacology 27:12, pages 1223-1237.
Crossref
Crossref
Evan C. Rosenberg, Richard W. Tsien, Benjamin J. Whalley & Orrin Devinsky. (2015) Cannabinoids and Epilepsy. Neurotherapeutics 12:4, pages 747-768.
Crossref
Crossref
Orrin Devinsky, Maria Roberta Cilio, Helen Cross, Javier Fernandez-Ruiz, Jacqueline French, Charlotte Hill, Russell Katz, Vincenzo Di Marzo, Didier Jutras-Aswad, William George Notcutt, Jose Martinez-Orgado, Philip J. Robson, Brian G. Rohrback, Elizabeth Thiele, Benjamin Whalley & Daniel Friedman. (2014) Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 55:6, pages 791-802.
Crossref
Crossref
Yahiya Y. Syed, Kate McKeage & Lesley J. Scott. (2014) Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis. Drugs 74:5, pages 563-578.
Crossref
Crossref
Erin L Karschner, W David Darwin, Robert S Goodwin, Stephen Wright & Marilyn A Huestis. (2011) Plasma Cannabinoid Pharmacokinetics following Controlled Oral Δ9-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration. Clinical Chemistry 57:1, pages 66-75.
Crossref
Crossref
Marilyn A. Huestis, Karl B. Scheidweiler, Takeshi Saito, Neil Fortner, Tsadik Abraham, Richard A. Gustafson & Michael L. Smith. (2008) Excretion of Δ9-tetrahydrocannabinol in sweat. Forensic Science International 174:2-3, pages 173-177.
Crossref
Crossref
Marilyn A. Huestis. (2007) Human Cannabinoid Pharmacokinetics. Chemistry & Biodiversity 4:8, pages 1770-1804.
Crossref
Crossref
Geoffrey W. Guy & Colin G. Stott. 2005. Cannabinoids as Therapeutics. Cannabinoids as Therapeutics
231
263
.
M. A. Huestis. 2005. Cannabinoids. Cannabinoids
657
690
.
Jonathan S. Berman, Catherine Symonds & Rolfe Birch. (2004) Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain 112:3, pages 299-306.
Crossref
Crossref